In vitrosusceptibility of 124Xanthomonas maltophilia(Stenotrophomonas maltophilia) isolates
- 1 January 1996
- Vol. 104 (1-6), 108-114
- https://doi.org/10.1111/j.1699-0463.1996.tb00695.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methodsAntimicrobial Agents and Chemotherapy, 1994
- A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapyAntimicrobial Agents and Chemotherapy, 1994
- Susceptibilities of 123 Xanthomonas maltophilia strains to clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacinAntimicrobial Agents and Chemotherapy, 1994
- Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitroAntimicrobial Agents and Chemotherapy, 1992
- Antibiotic susceptibility profile of Xanthomonas maltophilia in vitro activity of β-lactam/β-lactamase inhibitor combinationsDiagnostic Microbiology and Infectious Disease, 1991
- Septicemia Due to Xanthomonas Species and Non-Aeruginosa Pseudomonas SpeciesMedicine, 1990
- Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanateAntimicrobial Agents and Chemotherapy, 1989
- Outer Membrane Permeability and -Lactamase Content in Pseudomonas maltophilia Clinical Isolates and Laboratory MutantsClinical Infectious Diseases, 1988
- A Revised System for Antibiotic Sensitivity TestingScandinavian Journal of Infectious Diseases, 1981
- Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combinationAntimicrobial Agents and Chemotherapy, 1979